IL9 and non-small cell lung carcinoma: This analysis showed induction of IL-9+ cells in the tumoral region of the lung as compared to the control region in these lung sections derived from patients with NSCLC (Figure 1B and Supplementary Figure 1A). Patients included in this study were not treated with any immunotherapy before undergoing surgery analysis.